Evidence map›Paper›PMID 40876953›Full record

ArticleJournal of nuclear medicine : official publication, Society of Nuclear Medicine2025

[

Xiaoyan Li, Yajie Zhao, Jessica C Hsu, Eduardo A Sarduy, Todd E Barnhart, Jonathan W Engle, Weijun Wei, Shuo Hu, Weibo Cai

Abstract read
In one paragraph

Article in Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Xiaoyan LiDepartments of Radiology and Medical Physics, University of Wisconsin-Madison, Madison, Wisconsin.
Yajie ZhaoDepartments of Radiology and Medical Physics, University of Wisconsin-Madison, Madison, Wisconsin.
Jessica C HsuDepartments of Radiology and Medical Physics, University of Wisconsin-Madison, Madison, Wisconsin.
Eduardo A SarduyDepartments of Radiology and Medical Physics, University of Wisconsin-Madison, Madison, Wisconsin.
Todd E BarnhartDepartments of Radiology and Medical Physics, University of Wisconsin-Madison, Madison, Wisconsin.
Jonathan W EngleDepartments of Radiology and Medical Physics, University of Wisconsin-Madison, Madison, Wisconsin.
Weijun WeiDepartment of Nuclear Medicine, Institute of Clinical Nuclear Medicine, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Shuo HuDepartment of Nuclear Medicine, Xiangya Hospital, Central South University, Changsha, China; and wcai@uwhealth.org hushuoxy@csu.edu.cn.
Weibo CaiDepartments of Radiology and Medical Physics, University of Wisconsin-Madison, Madison, Wisconsin; wcai@uwhealth.org hushuoxy@csu.edu.cn.

Funding

UW COMPREHENSIVE CANCER CENTER SUPPORTP30CA014520 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI Justine Yang Bruce · 1985 to 2026
$142.6M
U.W. RADIOLOGICAL SCIENCES TRAINING PROGRAMT32CA009206 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI Bryan Patrick Bednarz · 1985 to 2026
$12.1M
NCI NIH HHS P30 CA014520NCI NIH HHS T32 CA009206
6 · The paper itself

Abstract

CD70 is a promising target for advancing the diagnosis and treatment of Burkitt lymphoma (BL). A

Indexed as

Burkitt LymphomaCD27 LigandGene Expression Regulation, NeoplasticPentetic AcidPositron-Emission TomographyAnimalsCell Line, TumorHumansMiceRadioactive TracersTissue DistributionCD27 LigandPentetic AcidRadioactive Tracers44ScBurkitt lymphomaCD70immuno-PETsingle-domain antibody

Identifiers

PMID40876953
PMCPMC12487755

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.